1. Home
  2. LFMD vs STXS Comparison

LFMD vs STXS Comparison

Compare LFMD & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$4.00

Market Cap

191.6M

Sector

Health Care

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.85

Market Cap

201.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFMD
STXS
Founded
1994
1990
Country
United States
United States
Employees
336
N/A
Industry
Medical/Nursing Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.6M
201.6M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
LFMD
STXS
Price
$4.00
$1.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$9.14
$4.00
AVG Volume (30 Days)
1.2M
394.8K
Earning Date
03-09-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
$17.76
$34.08
Revenue Next Year
$17.66
$35.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.60
$1.54
52 Week High
$15.34
$3.59

Technical Indicators

Market Signals
Indicator
LFMD
STXS
Relative Strength Index (RSI) 59.34 36.63
Support Level $3.43 N/A
Resistance Level $4.20 $2.52
Average True Range (ATR) 0.35 0.12
MACD 0.06 -0.01
Stochastic Oscillator 60.81 17.36

Price Performance

Historical Comparison
LFMD
STXS

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: